| Lord Appointed to National Advisory
Council
Jack Lord, M.D., Humana's
chief innovation officer, was invited recently by Tommy G. Thompson,
secretary of Health and Human Services, to serve on the National
Advisory Council for Healthcare Research and Quality.
The National Advisory Council for Healthcare and
Quality advises the United States Department of Health and Human
Services and the Agency for Healthcare Research and Quality (AHRQ)
on actions that enhance quality, improve the outcomes and reduce
the cost of health care services. The council also focuses on improving
access to and utilization of health care services through scientific
research and improvements in clinical practice and in the organization,
financing and delivery of service.
"The work done by AHRQ exemplifies the impact
of research translated into practice," said Lord. "It's
an honor to serve on such a prestigious council with the pre-eminent
thought leaders in the field. My role with the council will allow
me to strengthen my personal commitment to ensuring access to affordable,
quality health care in the United States."
This prestigious, three-year appointment places Lord
among only 21 distinguished health care leaders who serve on this
important council. His three-year term began on November 1, 2002.
Back to top
Lord Receives DMAA Award
 |
| Jack Lord (right), M.D., Humana's chief
innovation officer, receives the Karen Coughlin Award from DMAA. |
In November 2002, the Disease
Management Association of American (DMAA) announced that Jack Lord,
Humana’s chief innovation officer, is this year's recipient
of the Karen Coughlin Individual Disease Management Leadership Award.
DMAA is a nonprofit, voluntary membership organization
created in response to the need for a single voice and a more scientific
approach to the measurement of the success of disease management
programs. Under Lord’s leadership from 2001 to 2002, the DMAA
restructured its board, increased its domestic membership to include
all major national health insurers, nearly doubled its resources
and, with new chapters in Australia, Singapore and Europe, spawned
an international movement toward disease management and evidence-based
care.
One of only two individual awards given as part of
the Recognizing Excellence Awards Program, the Karen Coughlin award
honors Lord for his contributions to advancements in the care of
the millions of U.S. citizens with chronic disease.
"Disease management is increasingly being recognized
as one of the most important tools we have to proactively deal with
chronic disease in this country. All of us in the health care community
deserve recognition for our hard work in addressing the multiple
issues of disease management," said Lord.
Back to top
| Humana
Changes CAD Program
Some changes were made to Humana's
Coronary Artery Disease (CAD) program when Humana renewed
its contract for disease management services with CorSolutions
Inc. in October 2002.
Members of all acuity levels were eligible to participate
in the former CAD program. However, under the new CAD program,
participation is restricted to high-acuity members who require
the most attention and support. In addition, participation
in the program is now limited to nine months. Humana will
identify high-acuity participants through a combination of
factors, such as diagnosis, age, co-morbidities and utilization
history. Low- and moderate-acuity CAD members and high-acuity
members who had participated in the program for nine months
were transitioned out of the program in November and December.
Humana's Congestive Heart Failure (CHF) program, which also
is provided by CorSolutions, remains focused on high-acuity
New York Heart Association Class III and IV patients who may
stay in the program as long as they meet eligibility requirements.
Those requirements include, but are not limited to, enrollment
in a Humana plan as a primary health plan, remaining a Class
III or IV CHF patient and the absence of certain co-morbid
conditions.
If you have questions about these changes
or want more information about the CAD and CHF programs, please
call your local Humana medical director.
Back to top
|
|